Ranibizumab for retinal angiomatous proliferation in age-related macular degeneration

Eye advance online publication 12 February 2010; doi: 10.1038/eye.2010.9

Purpose: To assess the 1-year functional outcome and to evaluate the morphological changes after intravitreal injections of ranibizumab in eyes affected with retinal angiomatous proliferation (RAP) due to age-related macular degeneration (AMD).

Read more...